Publicaciones en colaboración con investigadores/as de Universidad del País Vasco/Euskal Herriko Unibertsitatea (9)

2010

  1. A semi-physiological-based pharmacokinetic/pharmacodynamic model to describe the effects of topotecan on B-lymphocyte lineage cells

    Pharmaceutical Research, Vol. 27, Núm. 3, pp. 431-441

2000

  1. Alpha1-acid glycoprotein (AAG) and serum protein binding of methadone in heroin addicts with abstinence syndrome

    International Journal of Clinical Pharmacology and Therapeutics, Vol. 38, Núm. 1, pp. 35-40

  2. Modeling of the in vivo antinociceptive interaction between an opioid agonist, (+)-O-desmethyltramadol, and a monoamine reuptake inhibitor, (-)-O-desmethyltramadol, in rats

    Journal of Pharmacology and Experimental Therapeutics, Vol. 295, Núm. 1, pp. 352-359

  3. Pharmacokinetic-pharmacodynamic modeling of the antinociceptive effects of main active metabolites of tramadol, (+)-O-desmethyltramadol and (-)-O- desmethyltramadol, in rats

    Journal of Pharmacology and Experimental Therapeutics, Vol. 293, Núm. 2, pp. 646-653

1999

  1. Altered plasma and brain disposition and pharmacodynamics of methadone in abstinent rats

    Journal of Pharmacology and Experimental Therapeutics, Vol. 288, Núm. 1, pp. 179-187

1997

  1. Pharmacokinetic-pharmacodynamic modeling of mivacurium in rats

    Journal of Pharmaceutical Sciences, Vol. 86, Núm. 2, pp. 252-256

1996

  1. Influence of plasma-protein binding on analgesic effect of methadone in rats with spontaneous withdrawal

    Journal of Pharmacy and Pharmacology, Vol. 48, Núm. 3, pp. 281-284

  2. The effect of changes in gastric pH induced by omeprazole on the absorption and respiratory depression of methadone

    Biopharmaceutics and Drug Disposition, Vol. 17, Núm. 7, pp. 551-563

1995

  1. Altered methadone analgesia due to changes in plasma protein binding: Role of the route of administration

    General Pharmacology, Vol. 26, Núm. 6, pp. 1273-1276